TB - TuberculosisKAP TBNCT07749872
KAP TB in Senior Management Officials of Companies With Increased Silica Exposure
An observational study of TB - Tuberculosis and Silicosis, run by Centre for Infectious Disease Research in Zambia at 1 site in Zambia.
Trial summary
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- TB - Tuberculosis, Silicosis, Occupational Exposure
- How many people
- 118 participants
- Where
- 1 siteZambia
- Study dates
- 2 Feb 2022to 28 Feb 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The sample population was drawn from the Zambia Chamber of Commerce and Industry (ZACCI), an umbrella organization representing businesses across all sectors. ZACCI advocates for workplace legislation and a conducive business environment. Companies known to produce silica dust were identified under categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. The sampling frame included 1 mining company, 73 construction companies, 1 cement company, 9 brick/tile companies, and 10 glass/ceramic companies. Each company was asked to nominate at least one senior official to complete the questionnaire, with a maximum of two responses per company. This ensured representation across industries while maintaining focus on individuals with policy-making authority.
Who may be able to join
- Companies known to produce silica dust
- members of ZACCI
- current active senior management role
Who cannot join
- none silica producing companies
- junior staff
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Knowledge, Attitude, and Practices Regarding TB Among Senior Management Officials of Companies With Increased Silica Dust Exposure in Lusaka and Southern Provinces of Zambia
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. The sample was drawn from companies registered under the Zambia Chamber of Commerce and Industry (ZACCI), focusing on those with known silica dust exposure. Each company was asked to provide one or two senior officials to participate. A total of 118 individuals completed the survey.
Data collection was carried out using a self-administered electronic questionnaire developed in line with WHO recommendations for TB KAP surveys. The questionnaire contained 28 mandatory closed-ended questions: 7 on knowledge, 8 on attitudes, and 13 on practices (with 5 practice questions excluded from scoring as they were programmatic). Responses were validated by three medical doctors, and scoring was based on correct answers. Knowledge, attitude, and practice scores were categorized into "poor" or "good" using mean or median cutoffs depending on distribution. Logistic regression was applied to explore associations between participant characteristics and KAP outcomes.
Read the detailed description
Tuberculosis (TB) continues to pose a significant global health burden, particularly among individuals in the economically productive age group of 15-64 years. In Zambia, 85% of TB cases occur in this demographic, underscoring the dual public health and socio-economic impact. The risk is compounded in industries with high exposure to crystalline silica dust, such as mining, construction, drilling, cement, brick, tile, glass, and ceramics manufacturing. Prolonged inhalation of silica dust can lead to silicosis, a condition that increases the risk of TB three to four times compared to individuals without silicosis. Even without silicosis, silica exposure alone elevates TB risk. Poor workplace conditions, including overcrowding and inadequate ventilation, further exacerbate transmission risks.
Recognizing these occupational hazards, the study aimed to assess the knowledge, attitudes, and practices (KAP) of senior management officials in companies with high silica exposure. These officials play a critical role in shaping workplace policies and interventions, making their understanding and attitudes toward TB prevention and management essential for effective workplace health strategies.
The research was conducted as a descriptive cross-sectional study between February and October 2022 in Lusaka and Southern provinces of Zambia. These provinces were selected due to their concentration of industries associated with silica dust exposure. The study focused on senior management officials, defined as either the most senior staff in an organization or heads of divisions/departments, given their influence on workplace health policies.
The sample population was drawn from the Zambia Chamber of Commerce and Industry (ZACCI), an umbrella organization representing businesses across all sectors. ZACCI advocates for workplace legislation and a conducive business environment. Companies known to produce silica dust were identified under categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. The sampling frame included 1 mining company, 73 construction companies, 1 cement company, 9 brick/tile companies, and 10 glass/ceramic companies.
Each company was asked to nominate at least one senior official to complete the questionnaire, with a maximum of two responses per company. This ensured representation across industries while maintaining focus on individuals with policy-making authority.
Data were collected using a multiple-choice electronic questionnaire developed in accordance with WHO guidelines for TB KAP surveys. The questionnaire was self-administered in English via Google Forms and contained 28 mandatory closed-ended questions:
- Knowledge: 7 questions
- Attitudes: 8 questions
- Practices: 13 questions (with 5 excluded from scoring as they were programmatic) Of the 28 questions, 21 were multiple-choice, while 7 required a single best answer. The questionnaire was distributed via email, with three reminders sent to encourage participation. Due to low response rates from email reminders, physical follow-ups were conducted. Ultimately, participants completed the survey independently on tablets between June and November 2022.
Responses were validated by three medical doctors. A response was considered correct if at least two doctors agreed. This ensured accuracy and minimized bias in scoring. Responses marked as "don't know," "not sure," or "other" were treated neutrally with a score of 0. Ambiguous "other" responses were excluded from analysis.
Survey responses were stored on Google Forms, downloaded into a CSV file, and imported into Python (version 3.8) for recoding. The dataset was then analyzed using STATA (version 18.5). Descriptive statistics were used to summarize participant characteristics and categorical variables.
A scoring system was applied:
- Knowledge: maximum of 17 points
- Attitudes: maximum of 7 points
- Practices: maximum of 14 points Correct responses scored 1, incorrect responses scored 0. Scores were categorized into "poor" or "good" based on mean or median cutoffs depending on distribution. Logistic regression was used to explore associations between participant characteristics (age, gender, industry, department) and KAP outcomes. Univariable analysis identified potential associations, followed by multivariable analysis to control for confounders. Variables with p-values above 0.05 were excluded unless only two variables remained significant, in which case the higher p-value variable was retained.
- Keywords
- TB, Tuberculosis, Knowledge, Attitude, Practice, Senior management, Silicosis, Silica Dust, non mining companies
- Medical subject headings
- Latent Tuberculosis, Silicosis, Tuberculosis, Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Senior management from companies known to produce silica dust | Categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Knowledge, attitudes, and practices (KAP) scores related to tuberculosis among senior management of manufacturing, construction, and mining companies associated with exposure to silica dust.
Descriptive Cross - sectional study
Measured: Conducted between February 2022 to October 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2026
- Study start2 Feb 2022
- Primary completion15 Oct 2022
- Study completion28 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TB - TuberculosisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 118 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre for Infectious Disease Research in Zambia
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07749872
- Sponsor's protocol ID
- 2327-2021 KAP TB
- Other IDs
- 72061120CA00001
- Acronym
- KAP TB
- Status last verified
- Aug 2026
- First submitted
- 31 Jul 2026
- Last updated
- 6 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Knowledge, Attitude, and Practices Regarding TB Among Senior Management Officials of Companies With Increased Silica Dust Exposure in Lusaka and Southern Provinces of Zambia
- ClinicalTrials.gov ID
- NCT07749872
- Acronym / sponsor ID
- KAP TB / 2327-2021 KAP TB
- Keywords
- TB, Tuberculosis, Knowledge, Attitude, Practice, Senior management, Silicosis, Silica Dust
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 118 participants (actual)
- Lead sponsor
- Centre for Infectious Disease Research in ZambiaUniversity, hospital or other
- Study start
- 2 Feb 2022 (actual)
- Primary completion
- 15 Oct 2022 (actual)
- Study completion
- 28 Feb 2023 (actual)
- First posted
- 6 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study was designed as a descriptive cross-sectional survey conducted between February and October 2022. Senior management officials were targeted because of their role in workplace policy and oversight. The sample was drawn from companies registered under the Zambia Chamber of Commerce and Industry (ZACCI), focusing on those with known silica dust exposure. Each company was asked to provide one or two senior officials to participate. A total of 118 individuals completed the survey.
Data collection was carried out using a self-administered electronic questionnaire developed in line with WHO recommendations for TB KAP surveys. The questionnaire contained 28 mandatory closed-ended questions: 7 on knowledge, 8 on attitudes, and 13 on practices (with 5 practice questions excluded from scoring as they were programmatic). Responses were validated by three medical doctors, and scoring was based on correct answers. Knowledge, attitude, and practice scores were categorized into "poor" or "good" using mean or median cutoffs depending on distribution. Logistic regression was applied to explore associations between participant characteristics and KAP outcomes.
Detailed description
Tuberculosis (TB) continues to pose a significant global health burden, particularly among individuals in the economically productive age group of 15-64 years. In Zambia, 85% of TB cases occur in this demographic, underscoring the dual public health and socio-economic impact. The risk is compounded in industries with high exposure to crystalline silica dust, such as mining, construction, drilling, cement, brick, tile, glass, and ceramics manufacturing. Prolonged inhalation of silica dust can lead to silicosis, a condition that increases the risk of TB three to four times compared to individuals without silicosis. Even without silicosis, silica exposure alone elevates TB risk. Poor workplace conditions, including overcrowding and inadequate ventilation, further exacerbate transmission risks.
Recognizing these occupational hazards, the study aimed to assess the knowledge, attitudes, and practices (KAP) of senior management officials in companies with high silica exposure. These officials play a critical role in shaping workplace policies and interventions, making their understanding and attitudes toward TB prevention and management essential for effective workplace health strategies.
The research was conducted as a descriptive cross-sectional study between February and October 2022 in Lusaka and Southern provinces of Zambia. These provinces were selected due to their concentration of industries associated with silica dust exposure. The study focused on senior management officials, defined as either the most senior staff in an organization or heads of divisions/departments, given their influence on workplace health policies.
The sample population was drawn from the Zambia Chamber of Commerce and Industry (ZACCI), an umbrella organization representing businesses across all sectors. ZACCI advocates for workplace legislation and a conducive business environment. Companies known to produce silica dust were identified under categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. The sampling frame included 1 mining company, 73 construction companies, 1 cement company, 9 brick/tile companies, and 10 glass/ceramic companies.
Each company was asked to nominate at least one senior official to complete the questionnaire, with a maximum of two responses per company. This ensured representation across industries while maintaining focus on individuals with policy-making authority.
Data were collected using a multiple-choice electronic questionnaire developed in accordance with WHO guidelines for TB KAP surveys. The questionnaire was self-administered in English via Google Forms and contained 28 mandatory closed-ended questions:
- Knowledge: 7 questions
- Attitudes: 8 questions
- Practices: 13 questions (with 5 excluded from scoring as they were programmatic) Of the 28 questions, 21 were multiple-choice, while 7 required a single best answer. The questionnaire was distributed via email, with three reminders sent to encourage participation. Due to low response rates from email reminders, physical follow-ups were conducted. Ultimately, participants completed the survey independently on tablets between June and November 2022.
Responses were validated by three medical doctors. A response was considered correct if at least two doctors agreed. This ensured accuracy and minimized bias in scoring. Responses marked as "don't know," "not sure," or "other" were treated neutrally with a score of 0. Ambiguous "other" responses were excluded from analysis.
Survey responses were stored on Google Forms, downloaded into a CSV file, and imported into Python (version 3.8) for recoding. The dataset was then analyzed using STATA (version 18.5). Descriptive statistics were used to summarize participant characteristics and categorical variables.
A scoring system was applied:
- Knowledge: maximum of 17 points
- Attitudes: maximum of 7 points
- Practices: maximum of 14 points Correct responses scored 1, incorrect responses scored 0. Scores were categorized into "poor" or "good" based on mean or median cutoffs depending on distribution. Logistic regression was used to explore associations between participant characteristics (age, gender, industry, department) and KAP outcomes. Univariable analysis identified potential associations, followed by multivariable analysis to control for confounders. Variables with p-values above 0.05 were excluded unless only two variables remained significant, in which case the higher p-value variable was retained.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Senior management from companies known to produce silica dust | – | –Categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The sample population was drawn from the Zambia Chamber of Commerce and Industry (ZACCI), an umbrella organization representing businesses across all sectors. ZACCI advocates for workplace legislation and a conducive business environment. Companies known to produce silica dust were identified under categories including mining, construction, cement manufacturing, brick and tile manufacturing, and glass and ceramic manufacturing. The sampling frame included 1 mining company, 73 construction companies, 1 cement company, 9 brick/tile companies, and 10 glass/ceramic companies. Each company was asked to nominate at least one senior official to complete the questionnaire, with a maximum of two responses per company. This ensured representation across industries while maintaining focus on individuals with policy-making authority.
Key inclusion criteria (3 listed)
- Companies known to produce silica dust
- members of ZACCI
- current active senior management role
Key exclusion criteria (2 listed)
- none silica producing companies
- junior staff
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Knowledge, attitudes, and practices (KAP) scores related to tuberculosis among senior management of manufacturing, construction, and mining companies associated with exposure to silica dust.
Time frame: Conducted between February 2022 to October 2022
Descriptive Cross - sectional study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for TB - Tuberculosis
RecruitingObservational study
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Tuberculosis
Not yet recruitingPhase 2
Re-evaluating the Duration in Children of TB Treatment
Tuberculosis
RecruitingPhase 1/2
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Tuberculosis
Active, not recruitingPhase 3
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
Tuberculosis, MDR
RecruitingPhase 2
Evaluating the Safety and Immunogenicity of MTBVAC
HIV I Infection, Tuberculosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of TB - Tuberculosis and Silicosis, run by Centre for Infectious Disease Research in Zambia at 1 site in Zambia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Zambia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Knowledge, attitudes, and practices (KAP) scores related to tuberculosis among senior management of manufacturing, construction, and mining companies associated with exposure to silica dust. (time frame: Conducted between February 2022 to October 2022). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.